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Background: Chromosome engineering encompasses a collection of homologous recombination-based techniques
that are employed to modify the genome of a model organism in a controlled fashion. Such techniques are widely
used in both fundamental and industrial research to introduce multiple insertions in the same Escherichia coli strain.
To date, λ-Red recombination (also known as recombineering) and P1 phage transduction are the most successfully
implemented chromosome engineering techniques in E. coli. However, due to errors that can occur during the
strain creation process, reliable validation methods are essential upon alteration of a strain’s chromosome.
Results and discussion: Polymerase chain reaction (PCR)-based methods and DNA sequence analysis are rapid and
powerful methods to verify successful integration of DNA sequences into a chromosome. Even though these
verification methods are necessary, they may not be sufficient in detecting all errors, imposing the requirement of
additional validation methods. For example, as extraneous insertions may occur during recombineering, we
highlight the use of Southern blotting to detect their presence. These unwanted mutations can be removed via
transducing the region of interest into the wild type chromosome using P1 phages. However, in doing so one
must verify that both the P1 lysate and the strains utilized are free from contamination with temperate phages, as
these can lysogenize inside a cell as a large plasmid. Thus, we illustrate various methods to probe for temperate
phage contamination, including cross-streak agar and Evans Blue-Uranine (EBU) plate assays, whereby the latter is a
newly reported technique for this purpose in E. coli. Lastly, we discuss methodologies for detecting defects in cell
growth and shape characteristics, which should be employed as an additional check.
Conclusion: The simple, yet crucial validation techniques discussed here can be used to reliably verify any
chromosomally engineered E. coli strains for errors such as non-specific insertions in the chromosome, temperate
phage contamination, and defects in growth and cell shape. While techniques such as PCR and DNA sequence
verification should standardly be performed, we illustrate the necessity of performing these additional assays. The
discussed techniques are highly generic and can be easily applied to any type of chromosome engineering.
Keywords: Chromosome engineering, Escherichia coli, Recombineering, P1 phage transduction, Strain validation,
EBU plate assay, Growth curve analysis, Cell shape analysisBackground
Modification of an organism’s phenotypes by altering its
chromosomal DNA sequence in a controlled manner
provides the fundamental motivation for chromosome
engineering [1]. This engineering comprises a collection
of techniques that can be applied to insert foreign DNA
sequences at a specific locus, delete the native sequence,
or alter the bases in the chromosomal DNA of a model* Correspondence: N.H.Dekker@tudelft.nl
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ium Escherichia coli (E. coli), used for many fundamental
studies in molecular and cell biology, and it is also uti-
lized for expressing novel proteins. The single, circular
chromosome of E. coli has been fully sequenced and
amply annotated, paving the way for researchers to pre-
cisely engineer its chromosome using a variety of methods
[2]. Most chromosome engineering techniques in E. coli
harness the properties of the recombinase family of en-
zymes, expressed by plasmids or bacteriophages, which re-
combine homologous linear DNA fragments into the host
chromosome [3].Access article distributed under the terms of the Creative Commons Attribution
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Table 1 Chromosome engineering techniques widely used in
E.coli
λ-Red recombination
The λ-Red recombination (or recombineering) approach has been
successfully implemented in many studies to engineer specific sites in
the E. coli chromosome [17]. In this approach, chromosomal sequences
are replaced by a linear DNA fragment (flanked with sequences
homologous to the region of interest) through the use of a temperature-
sensitive plasmid that expresses either the Red recombinase genes (bet,
gam and exo) from λ-phage [17] or the RecET proteins from Rac prophage
[18] upon induction. The linear DNA fragment of interest is usually
synthesized via PCR, in which case the homologous sequences (~50 bases)
are introduced through the employed primers. The recombined strain
is selected using a constitutively expressed antibiotic marker that is
integrated into the chromosome along with the insert of interest. This
technique may also be combined with FLP/FRT-based recombination,
in which the antibiotic marker is flanked by FRT sites that allow it to be
recombined out using the flippase (FLP) enzyme [19]. In this way, the
created strain may be employed in multiple rounds of chromosome
engineering using the same antibiotic marker [17, 20].
Generalized P1 phage transduction
Generalized P1 phage transduction is widely used to transfer mutations
from one E. coli strain to another with the same genetic background
[26, 27]. This approach is based on the fact that virulent P1 phages
commit errors while packaging their DNA into coat proteins: instead of
packaging their own genome, they package lysed host chromosomal DNA
fragments [28–30]. Such mis-packaged phages form approximately ~5 %
of the total phage population in a lysate. When they are transduced into
a different host, the chromosome fragment may be inserted precisely at
a homologous site using the RecA-dependent system [26]. Using this
approach, multiple insertions can be made into the ~4.6 Mb chromosome
of same E. coli strain, provided that they are separated by ~100 kb [31]. A
combination of λ-Red recombination, FLP/FRT recombination, and P1
phage transduction methods can also be used to introduce multiple
insertions into a single E. coli strain [6, 15].
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employed chromosome engineering tools in E. coli re-
search. The ability to fuse a fluorescent protein gene
with native genes [4] is an example that has opened up
the possibility of live cell imaging to visualize the dynam-
ics and stoichiometry of native proteins involved in key
biochemical processes such as DNA replication [5, 6],
transcription [7, 8], translation [7], chromosome segrega-
tion [9], cell signaling [10], and flagellar motor dynamics
[11]. Similarly, a high throughput study in which single
genes were systematically deleted from the E. coli chromo-
some has shed light on the (non)-essential character of
individual genes, and hence on the possibilities of creating
a minimal cell containing only the most essential genes
[12, 13]. In addition to such studies into fundamental as-
pects of molecular and cellular biology, chromosome engin-
eering is also used in industrial research to produce essential
bio-chemicals, bio-fuels, and precursors for pharmaceuti-
#cals on a large scale by engineering all necessary genes
into a single E. coli strain [14–16]. In industrial research,
chromosome engineering is typically preferred to conven-
tional cloning in plasmids, as it obviates the need for anti-
biotics to maintain gene presence [15].
For any research in which the chromosome is engi-
neered, it is essential to reliably verify that the process
has not inadvertently introduced anomalies into the gen-
ome. For example, the use of λ-Red recombination or
recombineering [17–20] (Table 1) may result in inser-
tions at undesired locations in the chromosome, a result
of sequence heterogeneities introduced during synthesis
of the requisite long primers [17, 21], the presence of an
unstable genomic region [22], or the occurrence of par-
tial gene duplication in the chromosome during the
strain creation process [23]. The latter is illustrated by
the gene duplication errors that occurred in 0.6 % of the
3864 single-gene deletion mutants of E. coli K12 strains
in the Keio collection [23]. Together with the intended
insertion which usually occurs at a probability of ~10−4
to 10−5 [24] non-specific mutations may occur and, they
are not detected easily using standard PCR techniques
[22]. When such errors occur, P1 phage transduction
(Table 1) can be performed to recover the strain of inter-
est, as the region of interest can be specifically transduced
into a clean wild type strain following recombineering
[25–31]. However, P1 phage transduction comes with its
own challenges, such as the potential contamination of
temperate phages in the phage stock that can lysogenize
as a large plasmid in the created strain. Hence, appropri-
ate validation of the chromosomally engineered strain re-
mains a critical step in the strain creation process.
Here, we describe in detail a number of general
methods for the validation of strains with altered chro-
mosomes, and accompany this description with experi-
mental results. We note that several of the techniquesdescribed here are individually well known to the scien-
tific community; however, frequently only the more
standard verification procedures for chromosome engin-
eering, PCR and DNA sequence analysis, are typically
reported. Grouping together the description of these
techniques, we bring to the increased attention of re-
searchers the most common defects that can arise during
strain creation, together with the appropriate methods to
verify them. In doing so, we hope to make these tech-
niques more readily accessible to a wider community, fa-
cilitating access to them by new researchers and/or those
engaged in cross-disciplinary study. We have organized
our description of these essential validation methods along
the lines of the irregularities that may occur: (i) non-
specific insertions in the chromosome; (ii) the contamin-
ation of temperate P1 phage in the engineered E. coli
strains; and (iii) defects in phenotypes such as cell growth
and morphology. The latter physiological aspect must be
taken into account if the results obtained from an engi-
neered E. coli strain are to be generalized to wild type E.
coli. Within each of these categories, we illustrate the
defects that can arise from errors in chromosome engin-
eering and describe various methods to detect them, using
as examples the creation of two E.coli AB1157 strains:
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microscopy [32] and pBad-DnaG in which an inducible
primase gene is inserted into the non-essential galK
chromosomal locus.
Results and discussion
Verification of an engineered sequence in the
chromosome
PCR and DNA sequence analysis are the techniques that
are widely performed and reported to verify whether a
chromosome engineering technique has successfully
modified the chromosomal DNA sequence. We per-
formed these well-known techniques as a first pass in
the validation process of strains created via λ-Red re-
combination. Specifically, we performed λ-Red recom-
bination to knock out the genes expressing the flagellar
motor proteins (ΔmotAB) in the E. coli AB1157 strain
(Methods section IA). The targeted gene was replaced
with the chloramphenicol resistance gene (CmR), which
was used as a selection marker to isolate the successfully
engineered colonies. To verify whether the insert (FRT-
CmR-FRT) was located at the intended site, we designed
primers that flank the region of interest (Fig. 1a, Table 2).
The positive results of a PCR reaction performed on the
16 selected colonies using flanking primers indicated
that the motAB genes in the chromosome were replaced
with the CmR gene (Fig. 1b). DNA sequence analysis
was performed to verify the recombineered region of the
chromosome (Methods section IIA). The quality of se-
quencing results also provides insights on the integrated
DNA sequence in chromosome. For example, if the
DNA sequence results show a double signal (i.e. signals
for two bases at the same position), it indicates sequence
heterogeneity of the integrated DNA amongst the cells
of a colony [33]. In our experiments, the DNA sequence
and its alignment with the template sequence revealed
that the motAB genes were successfully knocked out
without sequence errors in 9 out of 16 colonies (Table 3).
A representative DNA sequencing result of the Δmo-
tAB10 strain at the sites of integration and the corre-
sponding alignment with the expected template DNA
sequence are shown (Fig. 1c).
Multiple copies of the insert sequence (CmR) could
have recombined elsewhere in addition to the intended
site on the chromosome, and such extraneous insertions
can be detected using Southern blotting (Methods sec-
tion IIB) [22, 24, 34]. We performed this technique on
nine ΔmotAB strains and AB1157 strain as a negative
control, all of which were initially verified by PCR and
DNA sequence analysis. For this specific experiment, the
chromosomal DNA samples isolated from the strains
were first digested with two high fidelity restriction en-
zymes: EcoRI-HF and BamHI-HF, selected based on the
criteria detailed in Methods section IIB. The digestedDNA fragments were separated via agarose gel electro-
phoresis and were then transferred to a blotting mem-
brane to probe for the CmR gene. The DNA sequence
that serves as a probe was obtained by PCR-based amp-
lification of a 650 bp fragment obtained from the CmR
gene of template plasmid pKD3 (Table 2, Fig. 1d). This
single-stranded probe DNA was labelled directly with
thermo-stable alkaline phosphatase enzyme. Following
hybridization on the blotting membrane, this enzyme
catalyzes a chemi-luminescence reaction, thereby allow-
ing target DNA fragments complementary to the probe
to be detected on a CCD detector. Using this approach,
we observed that in two of the nine strains (ΔmotAB11
and ΔmotAB14) the CmR gene had recombined not only
at the intended region, but also at another non-essential
unknown region of the chromosome.
A comparison of the blotting results for ΔmotAB10
strain with single intended CmR insertion and Δmo-
tAB14 strain with extraneous insertion is shown (Fig. 1e).
We also verified that the ΔmotAB14 strain showed
increased chloramphenicol tolerance compared to the
ΔmotAB10 strain as a result of this additional insertion.
To do so, both strains were grown under constant shak-
ing at 37 °C and 350 rpm in 96 well plates containing LB
media with different concentrations of chloramphenicol,
and the optical density was measured at regular inter-
vals. While no growth was observed for the ΔmotAB10
strain in LB medium including an increased concentra-
tion of chloramphenicol (51 μg/mL compared to a nor-
mal dosage of 34 μg/mL), the growth of ΔmotAB14
strain remained unaffected (Fig. 1f ). These results dem-
onstrate that extraneous mutations may occur when per-
forming recombineering techniques [24], supporting the
need for strain verification steps like Southern blot ana-
lysis in addition to the standard methods of PCR and
DNA sequence analysis. The properly verified Δmo-
tAB10 strain generated in these experiments will be re-
ferred as ΔmotAB in what follows.
Detection of temperate phage contamination in a phage
lysate or a transduced strain
In a phage-transduced strain, temperate P1 bacteriophage
can lysogenize as a large plasmid and can replicate for
generations along with chromosome of the strain. To
demonstrate detection techniques for this phenomenon,
we first performed a sample P1 phage transduction experi-
ment. In this experiment, we employed a donor strain in
which the β-clamp gene (dnaN) is fused with the gene for
a yellow fluorescent protein adjacent to a kanamycin
marker (kanR), as reported in a recent study on DNA rep-
lication (Ypet-DnaN) [5]. Transduction of such a DNA se-
quence into the non-motile ΔmotAB strain can provide a
general approach for live cell imaging studies, whose focus
on the visualization of internal cellular dynamics benefits
Fig. 1 (See legend on next page.)
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Fig. 1 Verification of an engineered sequence in the chromosome. a The scheme depicts the changes at the recombineering site to create the
motAB gene knockout strain (ΔmotAB) using a chloramphenicol resistance gene (CmR). The positions of the flanking primers for the motAB
region (PmotABfw and PmotABrv) are marked, and the corresponding product lengths from PCR are indicated at the bottom. b PCR results of the
colonies obtained through recombineering. In lane M, 10 μL of DNA ladder was loaded. In lanes 1–16, 10 μL of PCR products from selected,
individual ΔmotAB colonies were loaded (ΔmotAB1 to ΔmotAB16). The PCR products of the control AB1157 strain were added in wells C1 and C2.
PCR products of the intended sizes are visible for all 16 selected colonies (~1.1 kbp marked with red arrow) as well as the AB1157 colonies
(~1.9 kbp). c A representative DNA sequencing result of the ΔmotAB10 strain at the sites of integration and the corresponding alignment with
the expected template DNA sequence are shown. d The important steps of making the Southern blot probes are illustrated. A 650 bp PCR
product is amplified from the template plasmid pKD3 and is then labelled with alkaline phosphatase to probe the CmR region (expected size:
6 kbp). e The ethidium bromide stained gel containing the DNA ladder (lane M), the restriction-digested AB1157 genome (lane 1), restriction-
digested genomes of two ΔmotAB colonies (lane 2: ΔmotAB10 and lane 3: ΔmotAB14 which were verified by PCR and DNA sequencing). The
Southern blot results show that the AB1157 sample in lane 1 has no insert, as expected; lane 2 with ΔmotAB10 has one band (6 kbp) at the
right fragment size showing that the integration was successful at the predicted site; lane 3 with ΔmotAB14 has two bands (6 kbp and 2 kbp).
f The growth of ΔmotAB10 and ΔmotAB14 strains in 96 well-plate reader containing LB medium with various concentrations of chloramphenicol
(17 μg/mL to 68 μg/mL). The results show that ΔmotAB14 strain containing the extraneous insertion grew at a higher concentration of
chloramphenicol (51 μg/mL) than the normal concentration (34 μg/mL), while the ΔmotAB10 did not grow at 51 μg/mL of chloramphenicol
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principle for our validation techniques, however, we
employed E. coli AB1157 strain as the recipient strain.
Prior to phage transduction in E. coli, P1 lysate stock
should be tested to determine both the infectivity of the
P1 phages in the stock as well as the sensitivity of the E.
coli strain used for transduction. To visualize plaque for-
mation and determine the infection titer value of the P1
stock, we performed a spot agar assay [25, 31]. In this
assay, different dilutions of P1 lysate stock are spotted
onto a lawn of cells grown on a soft LB agar (0.75 %).
The titer values are determined in terms of plaque form-
ing units per mL (pfu mL−1). We performed a spot agar
assay on the E. coli AB1157 strain (Methods section IIC)
and, by counting the plaques formed during the assay,
determined the titer of the tested P1 lysate to be ~7 ×
109 pfu mL−1 (Fig. 2a). The observed titer value was
found to be in the optimal range for successful transduc-
tion (109 to 1010 pfu mL−1) [25]. Phage transduction was
performed using the characterized lysate on Ypet-DnaN
as the donor strain and AB1157 as the recipient strain
(Methods section IB).
One must carefully ensure that phage-transduced cells
do not harbor temperate phages, which can result for
instance from the use of a P1 lysate contaminated with
temperate phages. This phenomenon can yield undesir-
able results, such as slow growth or abnormal physiology,
in the created strains [25]. Cells carrying temperate P1Table 2 Primer names and sequences used






PgalKrv 5′- CAGAACAGGCAGCAGAGCGT-3′phage DNA as a large plasmid are also prevented from
further P1 phage infection. This principle is used in cross-
streak agar assays to detect the presence of temperate
phages in the sample. In this technique, the colonies to be
tested are streaked across a ‘P1 lysate layer’ on a LB agar
plate, and the plate is incubated. If colony growth is not
observed on the streak beyond the lysate layer, then it
confirms the absence of temperate P1 phages from the
sample. However, if growth is observed beyond the lysate
layer, this indicates either the presence of temperate P1
phages or immunity of the strain to P1 phage infection
(Fig. 2b) [25]. We used the cross-streak agar assay to test
the colonies obtained from the phage transduction experi-
ment as well as control strains (Methods section IID). We
observed that 14 out of the 18 tested colonies from the
phage transduction experiment grew across the P1 lysate
streak, thereby demonstrating the presence of temperate
bacteriophages in these transduced colonies (Fig. 2c). The
remaining 4 colonies that were verified to be devoid of
temperate phages can be used for further experiments.
The best practice to avoid contamination by temperate
bacteriophages is to employ a verified virulent P1 lysate
in P1 phage transduction experiments. To facilitate this
verification of the P1 lysate, we have developed a rapid,
easily applicable assay to detect the presence of temper-
ate phages in the P1 lysate or in the employed strains.
This assay is derived from Evans Blue-Uranine (EBU)
plate assays, which are commonly used to verify pseudo-
lysogeny in P22 phage transduction experiments of
Salmonella strains [35]. We demonstrate here its first
use in P1 phage transduction experiments using E. coli
cells. When temperate phages are present in cells, a col-
ony formed from these cells will have a pH that differs
from that of uninfected cells as a result of pH lowering
through the lysis of pseudo-lysogenic cells [36]. This
property has been exploited in the EBU plate assay to
directly visualize colonies containing Evans blue stained
pseudo-lysogenic cells (Fig. 2d).
Table 3 Summary of DNA sequence analysis results for various
ΔmotAB colonies
Colony id Summary of DNA sequence analysis results
ΔmotAB1 Positive (Good signal at both the integration sites
and insert)
ΔmotAB2 Positive (Good signal at both the integration sites
and insert)
ΔmotAB3 Negative (Double signal at the end)
ΔmotAB4 Positive (Good signal at both the integration sites
and insert)
ΔmotAB5 Positive (Good signal at both the integration sites
and insert)
ΔmotAB6 Negative (Low signal)
ΔmotAB7 Negative (Double signal at the end)
ΔmotAB8 Negative (Double signal at the beginning)
ΔmotAB9 Negative (Low signal)
ΔmotAB10 Positive (Good signal at both the integration sites
and insert)
ΔmotAB11 Positive (Good signal at both the integration sites
and insert)
ΔmotAB12 Negative (Low signal with broad peaks)
ΔmotAB13 Negative (Low signal)
ΔmotAB14 Positive (Good signal at both the integration sites
and insert)
ΔmotAB15 Positive (Good signal at both the integration sites
and insert)
ΔmotAB16 Positive (Good signal at both the integration sites
and insert)
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cross-streak agar experiment were tested using the EBU
plate assay (Methods section IIE): they exhibited exclu-
sively dark green colonies (Fig. 2e), which we associate
with infection by temperate phages that results in a
change in cellular pH [36]. Conversely, the cells verified
to be free of phages displayed exclusively pale green
colonies (Fig. 2f ). To demonstrate that even minute con-
tamination of temperate phages in P1 lysate could be de-
tected, we mixed the contaminated lysate with a verified
virulent P1 stock of the Ypet-DnaN strain at a ratio of
1:100. We performed a P1 phage transduction experi-
ment as described above, and inspected 20 random
colonies using EBU plate assay. The results showed that
3 of the inspected 20 EBU plates contain few colonies
which are dark green in color, whereas neighboring pale
yellowish green-colored colonies are free of phages
(Fig. 2g), confirming the detectability of low-level tem-
perate phage contaminants in P1 lysate. We find that
the EBU plate assay is more convenient and reliable than
the cross-streak agar assay for the detection of temper-
ate phage contamination in transduced colonies and P1
lysates, and the phage-free colonies can be used for fur-
ther research.Evaluation of E. coli strains based on cellular growth or
morphology characteristics
Bacterial growth curve analysis provides an overview of
the growth behavior of the chromosomally engineered E.
coli strains. A typical bacterial growth curve starts with a
lag phase as the bacteria adapt to the fresh growth
medium, followed by a log phase in which growth is ex-
ponential. The final phase of the growth curve displays
stationary growth as a result of nutrient scarcity, after
which cells eventually die (Fig. 3a) [37]. Two important
parameters that can be determined using the technique
of growth curve analysis are the log-phase growth rate
(μ) and the duration of lag phase (τl) [38]. The log phase
doubling time (generation time, τd) is calculated from μ.
If growth defects are introduced during the strain cre-
ation process, they can be detected by comparing the
generation times of the parental strain with those of the
created strain. The literature suggests numerous models
and tools with which to perform this analysis [37, 38].
As an example, we have performed growth curve
validation for the AB1157 and ΔmotAB strains (Fig. 3a,
Methods section IIF). The critical step is to determine
which time points of the growth curve fall in the log
phase; fortunately, this is easily achieved by determining
the linear region of the semi-log plot of the same curve
(Fig. 3b). By fitting the log phase portion of the curve
with an exponential function, we calculated the growth
rates for each sample (Fig.3c). From the growth rates,
the mean generation times with standard deviation (SD)
for the AB1157 and ΔmotAB were found to be 39.2 ±
2.1 min and 38.7 ± 1.9 min, respectively. To determine
the statistical significance of this difference, we employed
t-test statistics for two independent sample means [39].
From the observed p-value of 0.68 (Table 4), we conclude
with 95 % confidence intervals that no significant differ-
ence in generation times can be attributed to the motAB
deletion genotype.
Cell morphology can be examined using numerous
methods including flow cytometry [40], atomic force mi-
croscopy [41], among others, and this essential pheno-
type can reveal the overall fitness of the chromosomally
modified strain. Here we describe an approach that em-
ploys phase contrast microscopy and automated image
analysis software MicrobeTracker (Methods section IIG)
[42]. Using this open-source software, numerous indica-
tors of cellular physiology such as cell volume and cell
length can be determined simultaneously in an auto-
mated fashion from phase contrast images of cells
(Fig. 3d). To illustrate this approach, we acquired images
of AB1157 and ΔmotAB cells grown in LB medium at
37 °C, and for each strain we analyzed approximately
350 cells. The mean cell volume (with SD) of AB1157
was found to be 5.5 ± 1.8 μm3 while that of ΔmotAB was
5.3 ± 1.6 μm3. In the same analysis, the mean cell length
Fig. 2 Detection of temperate phage contamination in a phage lysate or transduced strain. a The spot agar assay was performed using a serially
diluted P1 phage lysate starting from the un-diluted lysate (labelled as 1×) to the dilution factor of 1011 (labelled as 10−11). The results reveal that
plaques are observed at every concentration down to the 107th dilution. The P1 lysate stock was thereby determined to have an infection titer
value of 7 × 109 pfu mL−1. b A schematic diagram of a typical LB agar plate used for the cross-streak agar assay: The vertical dark region at the
center represents the zone of P1 lysate. The dot represents the location where the tested cells are inoculated at a safe distance from lysate zone,
and the horizontal solid lines represent either the temperate phage-infected cells that are growing across the lysate zone or the phage-free cells
that are not growing beyond the lysate zone. c The two representative plates of the cross-streak agar assay performed with the colonies obtained
from phage transduction experiment demonstrate that 14 of the 18 colonies tested are infected with temperate phages. The plate on the right
side indicates that the donor (D) and recipient (R) strains used are devoid of phages. d A scheme of the steps involved in Evans Blue-Uranine
(EBU) plate assay, explaining the principle of this technique to screen for temperate phage contamination. e Temperate phage-containing cells
verified using cross-streak agar assay grew as dark green colonies on EBU plate. f Cells verified to be free of phages grew as pale green colonies
on EBU plate. g An EBU plate assay was performed with the diluted cultures of colonies obtained from a P1 phage transduction experiment. A
representative result plate and an enlarged view of the colonies obtained from various EBU plates are shown. A mix of uninfected colonies (pale
yellowish green color) containing no temperate phages and colonies containing temperate phages (dark green) were observed on the plates
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and that of ΔmotAB was 3.4 ± 0.7 μm (Fig. 3f ). t-test
statistics were used to determine any significant cell
shape defects in the strains (Table 4) and revealed that
the mean cell volume and cell length are not signifi-
cantly different between the AB1157 and ΔmotAB
strains using 95 % confidence intervals from the ob-
served p-values (~0.1).
Application of the validation methods in a strain
engineered at a different chromosome locus
To demonstrate the effectiveness of the validation
methods described here, we applied them to a strain that
is chromosomally engineered at a different locus using λ-
Red recombination. In this strain, we replaced the en-
dogenous non-essential galK gene in the E.coli AB1157chromosome with an arabinose inducible primase gene
(pBad-DnaG) along with CmR gene (Fig. 4a). We per-
formed Southern blotting and we observed from its results
that extraneous insertions occurred in the created strain
along with the intended insertion. We then applied P1
phage transduction using verified virulent P1 phages to
transduce the intended insertion into the wild type E.coli
AB1157 strain. Again using Southern blotting, we found
that the P1 phage transduction step effectively produced
the desired strain, fully devoid of extraneous insertions
(Fig. 4b).
Conclusions
We have consolidated and explained in detail simple, yet
reliable, validation techniques which may be applied to
verify chromosomally engineered E. coli strains for non-
Fig. 3 Evaluation of E. coli strains based on cellular growth or morphology characteristics. a Growth curves of the AB1157 (black) and recombineered
ΔmotAB cells (red) in shake flasks containing LB medium at 37 °C and 250 rpm. b A simple method using semi-log plot to find the log phase of the
growth curve for AB1157 (black) and ΔmotAB (red) strains. The linear region of the semilog plot is the log phase of the growth curve. c The exponential
fitting of the selected log phase of the growth curve for AB1157 (black) and ΔmotAB (red) strains. From the fit (dotted lines), the growth rates (μ)
are determined as 1.11 h−1 and 1.13 h−1 for one sample of AB1157 and ΔmotAB strains repectively. d A sample phase contrast image of AB1157 cells
which were grown in LB medium at 37 °C and 250 rpm is shown. Such images were analyzed by MicrobeTracker software to calculate precisely the
cell length and volume for each cell. e & f The data of cell length and cell volume of ~350 cells for each strain are plotted using a Box and Whiskers
plot. The line within the box corresponds to the median value, the borders show the upper and lower quartiles (75 % and 25 %), and the whiskers
represent the maximum and minimum values
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contamination and general phenotype defects in growth
and cell-shape. We have described the aspects of strain
verification that common approaches such as PCR and
DNA sequence analysis do not report on, such as the
presence of extraneous insertions verified by Southern
blot analysis after recombineering. Additionally, we have
also adapted and described in detail the EBU plate assay
for the validation of E. coli strains created by the com-
monly used approach for chromosomal insertion, P1
phage transduction. In comparison to the cross-streak
agar assay, we find the EBU plate assay to be more con-
venient and reliable. The validation methods discussed
here are of widespread utility and can be applied to any
chromosome engineering technique. A summary of the
suggested workflow for the various validation steps thatTable 4 “t-test” statistics for two independent samples of AB1157 an
Parameter Mean Sta
Sample AB1157 ΔmotAB AB
Generation time [min] 39.2 38.7 2.1
Cell volume [μm3] 5.5 5.3 1.8
Cell length [μm] 3.3 3.4 0.9should be performed prior to using an E.coli strain for
further experiments is shown in Fig. 4c.Methods
All the chemicals and biological reagents used in this
study were ordered from Life Technologies (Europe).
The E. coli strains used in this research are the AB1157
strain [43] and its derivatives. Optical density measure-
ments were performed using the cell density meter
Ultraspec 10™ from GE Healthcare Europe GmBH (The
Netherlands). For each of the techniques described in
the main text, brief and specific descriptions are pro-
vided below, together with a detailed, step-wise protocol.
Our adaptations or improvements to standardized pro-
tocols are indicated in italics.d ΔmotAB strains’ generation time, cell volume and cell length





Fig. 4 Application of the validation methods in a strain engineered at a different chromosome locus. a The scheme depicts the replacement
of the endogenous non-essential galK gene with an arabinose inducible primase gene (pBad-DnaG) along with a CmR gene through λ-Red
recombination. The positions of the flanking primers for the galK gene (PgalKfw and PgalKrv) are marked, and the corresponding product lengths
from PCR are indicated, along with the probed region in chromosome and the expected band size from Southern blot analysis. b The Southern
blot results for the different experiments. Lane 1: the AB1157 sample in lane 1 has no insert, as expected. Lane 2: the pBad-DnaG strain obtained
through recombineering has multiple bands (mainly at ~9 kbp, 7 kbp, 6.5 kbp, and 2.5 kbp). Lane 3: the pBad-DnaG strain after P1 phage
transduction of the intended locus into the wild type AB1157 strain displays one band (~9 kbp) at the right fragment size, showing that the
extraneous insertions can be removed in the final strain using this approach. c A flow diagram summarizing the sequence of the various
validation techniques that should be performed prior to subsequent usage of the chromosomally engineered E.coli strain
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In this study we performed λ-Red recombination [17]
and P1 phage transduction [31] for the strain creation
using the following protocols.
λ-Red recombination (or recombineering)
This protocol is adapted from the literature [17, 24].
1. Perform PCR using a high fidelity polymerase (e.g.
Phusion polymerase from New England Biolabs® Inc)
from a linear or linearized DNA template containing
an antibiotic resistance gene (e.g. chloramphenicol
resistance (CmR)) by specially designed primers
(~70 bp) for generating homologous regions at
the ends.
2. Gel-purify the PCR product.
3. Transform a competent strain of interest with a
temperature sensitive plasmid coding for λ phage’sRed recombinase proteins (e.g. pKD46 [17]) as
described [44] and grow the cells overnight on a
agar plate at 30 °C in the presence of the
corresponding antibiotic.
4. Pick a colony from this plate and grow the cells
overnight in 5 mL LB medium containing respective
antibiotics at 30 °C, while shaking at 250 rpm.
5. Prepare three samples of 1.4 mL LB medium with
antibiotics, 50 μL of the overnight culture of cells
containing the pKD46 plasmid, 0.2 % arabinose (or
appropriate inducer used) along with one sample
without arabinose in separate microfuge tubes.
6. Incubate the cultures for 1.5 to 2 h at 37 °C, shaking
at 750 rpm, with the lids punctured.
7. Centrifuge the samples for 30 s at 12,000× g.
8. Discard the supernatant, and place the samples on ice.
9. Re-suspend the pellet with 1 mL chilled and sterile
double distilled water.
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again in double distilled water 3 times more.
11. Centrifuge the samples for 30 s at 12,000× g, and
remove the supernatant until ~50 μL is left in
the tubes.
12. Re-suspend the pellet in remaining volume, and
keep it on ice.
13. Add 1–3 μg of purified PCR product with a volume
not more than 5 μL from step 2 to the samples
on ice.
14. Include the following controls: a plasmid with same
antibiotic selection marker as a positive control and
sterile water as negative control.
15. Pipette the entire volume from a sample to an
electroporation cuvette, and electroporate the cells
at 1250 Volts using an electroporator (Eppendorf®).
16. Re-suspend the cells in the cuvette with 1 mL of
SOC medium by pipetting up and down, and
transfer them to a new sterile microfuge tube.
17. Incubate the samples in lid-punctured microfuge
tubes for 70 min at 37 °C while shaking at 750 rpm,
in order for the recombination to occur.
18. Pour LB agar plates containing an appropriate
concentration of the selection antibiotic. Do not
add the antibiotics required for the temperature
sensitive plasmid since the plasmid will be lost
during the culture.
19. Centrifuge the samples at 12,000× g for 30 s, and
remove 900 μL of the supernatant.
20. Re-suspend the cells in remaining volume, and
plate them onto LB agar plates.
21. Incubate the plates overnight at 37 °C.
22. Re-streak 10 colonies on a plate with the selection
antibiotic, and incubate the plate overnight at 37 °C.
P1 phage transduction
The protocol of P1 phage transduction that we adapted
from the literature is explained here [31]. The protocol
consists of two steps: (i) P1 lysate preparation from
donor strain and (ii) Phage transduction to recipient
strain. However, the infectivity of the source P1 lysate
stock should be determined first by using spot agar assay
(Methods section IIC).
i. P1 Lysate preparation
1. Inoculate the recipient strain and the donor
strain from the LB agar plates (e.g. from Methods
section IA step 22) in 5 mL of LB medium with
respective antibiotics, and grow the cells overnight
at 37 °C with shaking at 250 rpm.
2. Dilute in duplicate 0.5 mL of the overnight donor
culture into 4.5 mL of LB medium containing
60 μL of 1 M CaCl2 and 120 μL of 1 M MgSO4.
3. Incubate the cultures at 37 °C for 45 min.4. Add 100 μL of the P1 phage lysate stock that has
been prepared by infecting the wild type E.coli
strain. The volume of P1 lysate used may vary
depending on its infectivity (For example, if the
infectivity value of P1 lysate is 109 pfu mL−1, then
use 100 μL lysate).
5. Continue the incubation until the culture is lysed
or cell clumps are visible (usually around 3 to
4 h). The control culture without phages should
show normal growth.
6. Add 4 to 5 drops of chloroform to the lysed
culture, and stir the mixture well using a
vortex mixer.
7. After leaving the mixture to clarify for 5 min,
transfer the upper liquid layer to a new sterile
tube, and centrifuge the liquid for 20 min at
4200× g, 4 °C.
8. Pass the upper lysate layer further through a
0.45 μm filter to remove any viable donor cells.
9. Store the P1 lysate devoid of chloroform at 4 °C
for future use.
ii. Transduction
1. Dilute 100 μL of the overnight recipient culture
in 900 μL LB medium containing 75 mM CaCl2
and 150 mM MgSO4 in 5 microfuge tubes.
2. Add 5 μL, 50 μL, 100 μL or 200 μL of P1 lysate
both to the 4 tubes and, as a control, to the one
tube without lysate. The volumes of P1 lysate used
may vary depending on its infectivity. (For
example, if the infectivity value of P1 lysate is 109
pfu mL−1, then use the volumes mentioned here).
3. Incubate the cultures at 37 °C while shaking at
250 rpm for 30 min. Infection of recipient cells
occurs in this step.
4. Centrifuge the cells at 12,000× g for 3 min, and
discard the supernatant.
5. Re-suspend the pellet in 1 mL of LB medium
containing 20 mM sodium citrate (pH 5.5) to
reduce the infectivity of the adsorbed P1 phages
by chelating the divalent ions. The transduction
occurs during this step.
6. Incubate the cells for 1.5 to 2 h at 37 °C with
sufficient aeration and shaking at 250 rpm.
7. Centrifuge the cells and discard the supernatant.
8. Repeat step 6 and 7 twice to remove the phages as
much as possible.
9. Re-suspend the pellet in 100 μL LB medium
containing 20 mM sodium citrate (pH5.5).
10. Plate the cultures onto LB agar plates containing
20 mM sodium citrate with respective
antibiotics for selection.
11. Re-streak ~16 colonies onto LB agar plates
containing 20 mM sodium citrate and selection
antibiotics.
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Here we describe the step-by-step methodology of the
general validation techniques for chromosomal engi-
neered E. coli strains.
PCR and DNA sequencing
For the high throughput verification of the individual
colonies that are obtained from the strain creation
methods described above, a simple analytical PCR and
DNA sequencing are the widely used verification steps.
The accompanying steps are described below.
1. Design primers for PCR in such a way that the
sequence flanks the region of interest in the
chromosome, and the primer binding sites are not
farther than 100 bases from the recombination site.
2. Re-suspend each colony to be verified by PCR in
50 μL of sterile water, and streak 10 μL on LB agar
plates containing antibiotics.
3. Extract the DNA from the remaining cells into water
by boiling the samples for 5 min and centrifuging
them at 12,000× g for 1 min.
4. Perform a PCR reaction on this DNA using the
primers designed in step 1.
5. Verify the length of the PCR products using agarose
gel electrophoresis, and select colonies with proper
insert length for DNA sequence analysis of the
corresponding PCR product using the same flanking
primers. If necessary, use specific internal sequencing
primers to verify the correct insertion in the
chromosome.
6. Compare the DNA sequences by aligning it with the
corresponding theoretical sequences to check for
any point mutation or deletion introduced during
the strain creation process.
Southern blotting
The copy number of the recombined DNA in the
chromosome can be easily verified by using Southern
blotting [34]. In this study, we used the AlkPhos®
Direct labelling and detection system manufactured
by Amersham™ (GE healthcare Europe GmbH, The
Netherlands) because it is specially developed and well
optimized for blotting experiments. DNA extraction was
performed using Qiagen™ DNA isolation kit. We used high
fidelity restriction enzymes manufactured by New England
Biolabs® Inc.
1. Extract the genomic DNA from the strains to be
verified. Include the genomic DNA wild type strain
as control.
2. Select two or three restriction enzymes using
following criteria. The restriction sites must flank the
region of interest and should not be contained withinthe region itself. Since it is difficult to resolve DNA
fragments larger than 10 kb through gel electrophoresis
and to achieve the best resolution, it is a good practice
to make sure the size difference between the restricted
fragment and the region of interest (usually < 2 kb)
does not exceed 7 kb.
3. Perform the restriction digestion of ~10 μg genomic
DNA samples overnight preferably using the high
fidelity restriction enzymes to avoid star activity [45].
4. Separate the digested DNA samples in a 0.8 %
agarose gel by running electrophoresis overnight at a
constant current of 15 mA.
5. Depurinate the DNA fragments by incubating the
gel for 15 min in 0.1 M HCl solution on a plate
shaker, and wash subsequently four times with
double distilled water.
6. Denature the fragments in denaturing buffer (1.5 M
NaCl and 0.5 M NaOH) on a plate shaker for 15 min,
and wash four times with double distilled water.
7. Incubate the gel for 15 min in neutralizing buffer
(1.5 M NaCl and 0.5 M Tris base, pH 7.5) while
shaking, and wash four times with double
distilled water.
8. Transfer the DNA fragments by capillary action to a
pre-soaked Hybond-N+ membrane (GE Healthcare)
using 20 × SSC buffer (3 M NaCl and 0.3 M
tri-sodium citrate).
9. Pre-hybridize the blot with hybridization mix
(35 mL AlkPhos® Direct hybridization buffer, 1 g
NaCl and 1.4 g blocking agent-GE Healthcare) for
30 min at 55 °C in a rotary mixer.
10. Amplify the region of interest using specific PCR
primers from the source DNA (usually a template
plasmid or wild type chromosome). The optimal size
of the PCR product is ~200 to 1000 bp.
11. Denature the PCR product by boiling for 5 min,
chill it on ice, and label it using appropriate
reporters (e.g. thermo-stable alkaline phosphatase)
that can catalyze non-luminescent substrates and
yield luminescent products. The labeled PCR
product can then be used as a DNA probe.
12. Add the DNA probe to the membrane in the
hybridization buffer, and hybridize the probe in a
rotary mixer at 55 °C overnight.
13. Wash the membrane in rotary shaker at 55 °C with
100 mL wash buffer 1 for 10 min (pH: 7; 2 M Urea,
0.1 % SDS, 0.15 M NaCl, 0.05 M NaH2PO4, 1 mM
MgCl2, and 1 g Blocking reagent)
14. Wash the membrane twice with 100 mL wash
buffer 2 (pH: 10; 3 g Tris base, 2.8 g NaCl and
0.2 M MgCl2) in plate shaker at room temperature
for 10 min.
15. Incubate the membrane, with 3 mL non-luminescent
substrate for 5 min and dry the membrane.
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chemi-luminescence on the blot using appropriate
detectors. The resulting number of bands obtained is
indicative for the copy number of the recombined
DNA in the chromosome.
Spot agar assay
The infectivity of the phages in a P1 lysate can be deter-
mined by a spot agar assay. This method is adapted from
Ref. [31].
1. Add CaCl2 to the overnight culture of the recipient
strain from the phage transduction step such that
the final concentration is 5 mM.
2. Serially dilute the P1 lysate to the order of 10−10
using LB medium containing 75 mM CaCl2 and
150 mM MgSO4. Make sure to change the pipette
tips during the dilution step.
3. Mix 0.25 mL of cell culture with 2.5 mL of molten
LB top agar (0.75 %) containing 2.5 mM CaCl2.
4. Pour the mixture onto LB agar (1.5 %) plates
containing 2.5 mM CaCl2 and let it solidify.
5. Spot 10 μL of each phage stock dilution onto the
lawn of cells.
6. Keep the plates upright, and after the spots are dry,
incubate them at 37 °C overnight.
7. Calculate the titer value in pfu mL−1 by counting the
number of plaques in the lowest concentration spot,
then multiplying it with the order of dilution (e.g.
107) and finally by the factor 100 (to account for
10 μL volume used).
Cross-streak agar assay
The presence of temperate phages in phage-transduced
colonies can be tested by a cross-streak agar assay. This
method is adapted from Ref. [25].
1. Prepare a LB agar plate containing 2.5 mM CaCl2.
2. Draw a straight line on the back of plate across the
middle and well-spaced dots on one side (Fig. 2b).
3. Holding the plate in a slanting position, pour 50 μL
of phage lysate on the LB agar from one end of the
straight line.
4. Tilt the plate back to uniformly distribute the lysate
around the straight line.
5. Take a colony or liquid overnight culture to be
tested for temperate phages with the broad side of
the inoculation needle.
6. Place a dot of the colony or culture at the marked
location and leaving a few millimeters space streak
the colony or culture perpendicularly across the
phage lysate.
7. Transfer the plate carefully to incubator, and
incubate overnight at 37 °C.Evans Blue-Uranine (EBU) plate assay
The phage-transduced colonies can be tested for tem-
perate phage contamination and can be cured of phages
using EBU plate assay described below. The method is
adapted from Ref. [46] for E. coli strains.
1. Make agar plates from 1 L of molten LB agar
containing 40 mL of 12.5 % K2HPO4, 1.25 mL of 1 %
Evans Blue stain solution, 250 μL of 10 % uranine
solution and if necessary antibiotics.
2. Store the plates in dark at 4 °C. Since Evans Blue
stain is carcinogenic the plates must be handled
carefully with gloves, and it is usually a good practice
to autoclave and dispose in the carcinogenic waste.
3. Inoculate the colonies obtained from a phage
transduction experiment in LB medium, and grow
them for 3 h at 37 °C with shaking at 250 rpm.
4. Dilute the exponentially growing LB cultures 100
times, and spread 50 μL of the culture uniformly
across the EBU plates.
5. Incubate overnight at 37 °C in the dark.
6. Analyze the colonies. The colonies without temperate
phages appear pale yellow in color while those with
temperate phages are colored dark green.
Growth curve analysis
Growth curve analysis of the E. coli strains can be
performed using shake flasks as described below. In
this study, we used MS Excel and MATLAB to
analyze the data.
1. Dilute in triplicate overnight cultures of the wild type
and the strain to be verified to an OD550nm of 0.01 in
50 mL fresh medium.
2. Grow the cells at 37 °C in a shaking incubator
(250 rpm).
3. Use sterile disposable cuvettes and aseptic conditions
to note the OD550nm of 1 mL aliquot from each
culture sample using a cell-density meter.
4. Add back the culture aliquot to the sample after the
measurement in order to keep the culture volume
constant.
5. Steps 3 and 4 are repeated at an interval of 15 min
until the OD550nm is a constant value.
6. Plot the OD550nm values against time in min to get a
sigmoidal curve in this plot.
7. Plot the OD550nm values in logarithmic scale, the
exponential phase of the growth curve can be
identified as the distinct linear part (Fig. 3b,c), and
perform an exponential fit only on the OD550nm
values of this phase in the growth curve for each
sample to find the growth rate (μ) [38].
8. Calculate the generation time (τd) from μ using the
formula: τd = ln (2)/μ.
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experiment, and average the generation times for 6
samples of the strain to be verified. The result can
then be compared to the average generation time of
the wild type strain using t-test for two independent
sample means [39].
Detection for cell-shape defects by microscopy
Phase-contrast microscopy is a powerful technique to
determine the cell-shape characteristics of a bacterium.
In this study, it was performed using a Nikon Ti™ micro-
scope with a 100× objective and an Andor iXon™ Ultra
897 EMCCD camera.
1. Grow the LB culture of the strain to be verified until
it reaches the exponential phase OD550nm is ~ 0.3
to 0.4.
2. Centrifuge 1 mL of the culture at 12,000× g for
1 min, and remove the supernatant.
3. Re-suspend in 250 μL of fresh medium, and pipette
5 μL of concentrated culture on a pad of agarose
(1.5 %) flattened on a microscopic slide. Let the fluid
evaporate.
4. Place a sterile and clean cover-glass on top of the
cells, and press gently using tweezers.
5. Analyze the cells on a phase contrast microscope
using an objective with a magnification >60× and a
digital camera.
6. For a robust analysis, acquire the images with at
least ~100 separate cells within a field of view.
7. Store the images in greyscale tiff format, and analyze
them using MicrobeTracker software to accurately
determine the cell shape defects [42].
8. Export the analyzed data from the software in CSV
format for further analysis e.g. t-test statistics and
representation of data, e.g. a Box and Whiskers plot.
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